» Articles » PMID: 17566573

NGAL (neutrophil Gelatinase-associated Lipocalin) and Cystatin C: Are They Good Predictors of Contrast Nephropathy After Percutaneous Coronary Interventions in Patients with Stable Angina and Normal Serum Creatinine?

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2007 Jun 15
PMID 17566573
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to assess whether NGAL and cystatin C could predict contrast-induced nephropathy in non-diabetic patients (n=60, mean age 60+/-11 years) with normal serum creatinine undergoing elective PCI. We found a significant rise in serum NGAL after 2, 4 and 8 h, and in urinary NGAL after 4, 8 and 24 h after PCI. Cystatin C rose significantly 8 and 24 h after the procedure. Prevalence of CIN was 10%. We found 90% sensitivity and 74% specificity of serum and 76% sensitivity and 80% specificity of urinary NGAL increase. NGAL may represent a sensitive early biomarkers of renal impairment after PCI.

Citing Articles

Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years.

Chen Y, Fu Y, Wang S, Chen P, Pei Y, Zhang J Cardiovasc Diabetol. 2022; 21(1):252.

PMID: 36397150 PMC: 9682485. DOI: 10.1186/s12933-022-01668-5.


Neutrophil Gelatinase-Associated Lipocalin as a Marker for Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Prospective Observational Analysis.

Sahu A, Goel P, Khanna R, Kumar S, Kapoor A, Tewari S Indian J Nephrol. 2022; 32(3):247-255.

PMID: 35814328 PMC: 9267084. DOI: 10.4103/ijn.IJN_418_20.


Comparison of Different Hydration Strategies in Patients with Very Low-Risk Profiles of Contrast-Induced Nephropathy.

Miao S, Xue Z, Zhang Y, Zhang H, Che J, Liu T Med Sci Monit. 2021; 27:e929115.

PMID: 33927176 PMC: 8095087. DOI: 10.12659/MSM.929115.


Potential Role of Vitamin C Intracoronary Administration in Preventing Cardiac Injury After Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction.

Shafaei-Bajestani N, Talasaz A, Salarifar M, Pourhosseini H, Sadri F, Jalali A J Res Pharm Pract. 2019; 8(2):75-82.

PMID: 31367642 PMC: 6636420. DOI: 10.4103/jrpp.JRPP_18_78.


Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial.

Aslanabadi N, Afsar Gharebagh R, Moharramzadeh S, Entezari-Maleki T Int Urol Nephrol. 2019; 51(4):699-705.

PMID: 30830654 DOI: 10.1007/s11255-019-02104-6.